VERO vs. ICU, BTCY, PAVM, DHAI, SSKN, CODX, MHUA, NURO, POAI, and INBS
Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include SeaStar Medical (ICU), Biotricity (BTCY), PAVmed (PAVM), DIH Holding US (DHAI), STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), Meihua International Medical Technologies (MHUA), NeuroMetrix (NURO), Predictive Oncology (POAI), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry.
Venus Concept vs.
SeaStar Medical (NASDAQ:ICU) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, community ranking, dividends, media sentiment, institutional ownership and valuation.
SeaStar Medical has higher earnings, but lower revenue than Venus Concept. SeaStar Medical is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.
In the previous week, Venus Concept had 2 more articles in the media than SeaStar Medical. MarketBeat recorded 5 mentions for Venus Concept and 3 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.79 beat Venus Concept's score of -0.28 indicating that SeaStar Medical is being referred to more favorably in the media.
SeaStar Medical has a net margin of 0.00% compared to Venus Concept's net margin of -74.62%.
Venus Concept received 33 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.
SeaStar Medical has a beta of -0.9, suggesting that its stock price is 190% less volatile than the S&P 500. Comparatively, Venus Concept has a beta of -0.03, suggesting that its stock price is 103% less volatile than the S&P 500.
1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 87.4% of Venus Concept shares are held by institutional investors. 1.3% of SeaStar Medical shares are held by company insiders. Comparatively, 28.0% of Venus Concept shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
SeaStar Medical and Venus Concept tied by winning 7 of the 14 factors compared between the two stocks.
Get Venus Concept News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Venus Concept Competitors List
Related Companies and Tools
This page (NASDAQ:VERO) was last updated on 5/22/2025 by MarketBeat.com Staff
